{"product_id":"ambulatory-polysomnography-psg-systems-market-by-product-up-to-12-channel-psg-systems-up-to-24-channel-psg-systems-up-to-32-channel-psg-systems-above-32-channel-psg-systems-by-application-obstructive-sleep-apnea-narcolepsy-chronic-insomnia-oth","title":"Ambulatory Polysomnography (Psg) Systems Market By Product (Up to 12 Channel PSG Systems, Up to 24 Channel PSG Systems, Up to 32 Channel PSG Systems, Above 32 Channel PSG Systems), By Application (Obstructive Sleep, Apnea Narcolepsy, Chronic Insomnia, Oth","description":"\u003cp\u003eAmbulatory Polysomnography (Psg) Systems Market By Product (Up to 12 Channel PSG Systems, Up to 24 Channel PSG Systems, Up to 32 Channel PSG Systems, Above 32 Channel PSG Systems), By Application (Obstructive Sleep, Apnea Narcolepsy, Chronic Insomnia, Others), By End-user (Hospitals, Sleep Laboratories, Home Care Settings): Global Opportunity Analysis and Industry Forecast, 2022-2031\u003cbr\u003e\nThe global ambulatory polysomnography systems market is envisioned to garner $570.7 million by 2031, growing from $327.0 million in 2021 at a CAGR of 6.0% from 2022 to 2031.\u003c\/p\u003e\n\n\u003cp\u003eAmbulatory polysomnography (Amb-PSG), also known as type II PSG, can be used to identify different sleep disorders by characterizing sleep stages and quantifying arousals, total sleep time (TST), and an accurate respiratory disturbance index (RDI). Ambulatory polysomnography systems are in high demand among patients suffering from a variety of sleep disorders due to the benefits they provide. This is propelling the ambulatory polysomnography systems market.\u003c\/p\u003e\n\n\u003cp\u003eThe majority of the population, particularly in rural regions, is uninformed of the dangers of sleep apnea. Sleep disorders that go untreated can lead to chronic ailments like heart failure, stroke, high blood pressure, diabetes, and obesity. This can result in major health issues such as uncontrolled blood pressure, heart attacks, weakened and restricted blood vessels in the kidneys, and aneurysms. The population's lack of awareness about sleeping difficulties is expected to stymie the growth of the ambulatory polysomnography systems market in the near future.\u003c\/p\u003e\n\n\u003cp\u003eTechnological improvements in the sleep care business can be identified as a driving force in this market. The ambulatory polysomnography systems market is growing steadily due to numerous revolutionary technologies such as portable devices, smartphone applications, telemedicine, and so on. Wireless and portable polysomnography systems, like as Nox Medical's Nox A1s PSG, have benefited from research and development. Wireless capabilities give patients with a sense of liberty by allowing them freedom of movement while they are being diagnosed. This will have a beneficial impact on the growth of the ambulatory polysomnography systems market.\u003c\/p\u003e\n\n\u003cp\u003eThe global market has benefited by the outbreak of the COVID-19 pandemic. Key participants claimed considerable revenue growth as a result of an increase in the number of patients suffering from sleep difficulties as a result of the COVID19 pandemic. According to the poll, 70% of respondents have experienced one or more new sleep issues since the start of the COVID-19, leading to an increase in the use of sleep apnea equipment. As a result of this, the PSG systems’ businesses launched a clinically certified, low-touch CPAP Mask Selector tool that can be utilized remotely from the patient's home.\u003c\/p\u003e\n\n\u003cp\u003eThe key players profiled in this report include Koninklijke Philips N.V., Natus Medical Incorporated, Nihon Kohden Corporation, Nox Medical, Löwenstein Medical Technology GmbH + Co. KG., neurosoft, Cadwell Industries Inc., SOMNOmedics GmbH, Compumedics Limited, and Neurovirtual \/ Sleepvirtual.\u003c\/p\u003e\n\n\u003cp\u003eKey Benefits For Stakeholders\u003c\/p\u003e\n\n\u003cp\u003eThis report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the ambulatory polysomnography (psg) systems market analysis from 2021 to 2031 to identify the prevailing ambulatory polysomnography (psg) systems market opportunities.\u003cbr\u003e\nThe market research is offered along with information related to key drivers, restraints, and opportunities.\u003cbr\u003e\nPorter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.\u003cbr\u003e\nIn-depth analysis of the ambulatory polysomnography (psg) systems market segmentation assists to determine the prevailing market opportunities.\u003cbr\u003e\nMajor countries in each region are mapped according to their revenue contribution to the global market.\u003cbr\u003e\nMarket player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.\u003cbr\u003e\nThe report includes the analysis of the regional as well as global ambulatory polysomnography (psg) systems market trends, key players, market segments, application areas, and market growth strategies.\u003c\/p\u003e\n\n\u003cp\u003eKey Market Segments\u003c\/p\u003e\n\n\u003cp\u003eBy Product\u003c\/p\u003e\n\n\u003cp\u003eUp to 12 Channel PSG Systems\u003cbr\u003e\nUp to 24 Channel PSG Systems\u003cbr\u003e\nUp to 32 Channel PSG Systems\u003cbr\u003e\nAbove 32 Channel PSG Systems\u003c\/p\u003e\n\n\u003cp\u003eBy Application\u003c\/p\u003e\n\n\u003cp\u003eObstructive Sleep\u003cbr\u003e\nApnea Narcolepsy\u003cbr\u003e\nChronic Insomnia\u003cbr\u003e\nOthers\u003c\/p\u003e\n\n\u003cp\u003eBy End-user\u003c\/p\u003e\n\n\u003cp\u003eHospitals\u003cbr\u003e\nSleep Laboratories\u003cbr\u003e\nHome Care Settings\u003c\/p\u003e\n\n\u003cp\u003eBy Region\u003c\/p\u003e\n\n\u003cp\u003eNorth America\u003cbr\u003e\nU.S.\u003cbr\u003e\nCanada\u003cbr\u003e\nMexico\u003cbr\u003e\nEurope\u003cbr\u003e\nGermany\u003cbr\u003e\nUK\u003cbr\u003e\nFrance\u003cbr\u003e\nSpain\u003cbr\u003e\nItaly\u003cbr\u003e\nRest of Europe\u003cbr\u003e\nAsia-Pacific\u003cbr\u003e\nChina\u003cbr\u003e\nJapan\u003cbr\u003e\nIndia\u003cbr\u003e\nSouth Korea\u003cbr\u003e\nAustralia\u003cbr\u003e\nRest of Asia-Pacific\u003cbr\u003e\nLAMEA\u003cbr\u003e\nBrazil\u003cbr\u003e\nUnited Arab Emirates\u003cbr\u003e\nSaudi Arabia\u003cbr\u003e\nSouth Africa\u003cbr\u003e\nRest of LAMEA\u003cbr\u003e\nKey Market Players\u003cbr\u003e\nCadwell Industries Inc.\u003cbr\u003e\nCompumedics Limited\u003cbr\u003e\nCompumedics Limited\u003cbr\u003e\nKoninklijke Philips N.V.\u003cbr\u003e\nLöwenstein Medical Technology GmbH + Co. KG.\u003cbr\u003e\nNatus Medical Incorporated\u003cbr\u003e\nneurosoft\u003cbr\u003e\nNihon Kohden Corporation\u003cbr\u003e\nNox Medical\u003cbr\u003e\nSOMNOmedics GmbH\u003c\/p\u003e\n\n\u003cp\u003ePlease Note: It will take 7-10 business days to complete the report upon order confirmation.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"May, 2023 \/ 280 Pages \/ MCW16241284","offer_id":47657811345714,"sku":null,"price":4608.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/ambulatory-polysomnography-psg-systems-market-by-product-up-to-12-channel-psg-systems-up-to-24-channel-psg-systems-up-to-32-channel-psg-systems-above-32-channel-psg-systems-by-application-obstructive-sleep-apnea-narcolepsy-chronic-insomnia-oth","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}